A two-cohort feasibility study on polyglycolic acid yarn implantation for abolition of saphenous vein reflux

First-in-human use of an endovenous PGA yarn implant for occlusion of refluxing GSVs proved to be feasible, with no serious adverse events. However, recanalization was observed during a period of 6 months in 31% of patients.